# Northwest Biotherapeutics Inc: Form 8-K, filed Nov 29, 2021

- Company: [Northwest Biotherapeutics Inc](/companies/nwbo.md) (CIK 1072379)
- Form: 8-K
- Filed: 2021-11-29
- Accepted by EDGAR: Nov 29, 2021, 16:29 ET
- Period: 2021-11-22
- Accession: 0001104659-21-144456
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1072379/000110465921144456/tm2134065d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1072379/000110465921144456/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1072379/000110465921144456/tm2134065d1_8k.htm

Filed Nov 29, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-144456. Last ingested by Listed: Nov 14, 2026, 21:35 ET. No prices; not investment advice.
